A jury found that competitor EOFlow and former executives misappropriated trade secrets for Insulet’s Omnipod insulin pumps.

The lawsuit revolved around Insulet's Omnipod tubeless insulin pump – used with continuous glucose monitors (CGMs) to create ...

A federal jury on Tuesday awarded Insulet $452 million in its patent skirmish with EOFlow over insulin patch pumps. The jury awarded Insulet $170 million in compensatory damages from EOFlow and an ...

The company said it had restarted production of intravenous solutions on two lines in November, and added they were manufacturing 1-liter IV solution bags, the most commonly used size by hospitals and ...

Insulet (Nasdaq:PODD) announced that it successfully defended its intellectual property against EOFlow in U.S. federal court.

Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case ... announces resignation ahead of Trump term Reuters, the news and media division of Thomson Reuters, is the world ...

This briefing covers significant developments in health, including a revised deal between GSK and China's Zhifei, FDA ...

EOFlow Co. Ltd. must pay Insulet Corp. $452 million for stealing trade secrets related to its insulin pumps, a Massachusetts federal jury ruled. Insulet established the Korea-based company stole four ...

Medical device maker Insulet convinced a jury that Korean rival EOFlow owes it $452 million in damages for stealing trade ...